Sign In

Login

Password

Forgot Password ? Sign Up

Blood–spinal cord barrier (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Blood–spinal cord barrier" in English language version.

refsWebsite
Global rank English rank
10nih.gov
4th place
4th place
8doi.org
2nd place
2nd place
2ncsu.edu
2,542nd place
1,675th place

doi.org

  • Nicaise C, Soyfoo MS, Authelet M, De Decker R, Bataveljic D, Delporte C, Pochet R (December 2008). "Aquaporin-4 Overexpression in Rat ALS Model". The Anatomical Record. 292(2):207-213. https://doi.org/10.1002/ar.20838
  • Benoit Aubé, Sébastien A. Lévesque, Alexandre Paré, Émilie Chamma, Hania Kébir, Roser Gorina, Marc-André Lécuyer, Jorge I. Alvarez, Yves De Koninck, Britta Engelhardt, Alexandre Prat, Daniel Côté and Steve Lacroix (July 2014). "Neutrophils Mediate Blood–Spinal Cord Barrier Disruption in Demyelinating Neuroinflammatory Diseases". Journal of Immunology. 204(9). DOI: https://doi.org/10.4049/jimmunol.1400401
  • Pardridge W. M. (2012). Drug transport across the blood–brain barrier. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 32(11), 1959–1972. https://doi.org/10.1038/jcbfm.2012.126
  • Hladky, S. B., & Barrand, M. A. (2018). Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood–brain barrier. Fluids and barriers of the CNS, 15(1), 30. https://doi.org/10.1186/s12987-018-0113-6
  • Wang, D., Wang, C., Wang, L., & Chen, Y. (2019). A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment. Drug delivery, 26(1), 551–565. https://doi.org/10.1080/10717544.2019.1616235
  • Wong, A. D., Ye, M., Levy, A. F., Rothstein, J. D., Bergles, D. E., & Searson, P. C. (2013). The blood-brain barrier: an engineering perspective. Frontiers in neuroengineering, 6, 7. https://doi.org/10.3389/fneng.2013.00007
  • Hladky, S. B., & Barrand, M. A. (2016). Fluid and ion transfer across the blood-brain and blood-cerebrospinal fluid barriers; a comparative account of mechanisms and roles. Fluids and barriers of the CNS, 13(1), 19. https://doi.org/10.1186/s12987-016-0040-3
  • Gonzales-Portillo, G. S., Sanberg, P. R., Franzblau, M., Gonzales-Portillo, C., Diamandis, T., Staples, M., Sanberg, C. D., & Borlongan, C. V. (2014). Mannitol-enhanced delivery of stem cells and their growth factors across the blood-brain barrier. Cell transplantation, 23(4-5), 531–539. https://doi.org/10.3727/096368914X678337

ncsu.edu

doi-org.prox.lib.ncsu.edu

  • Bartanusz V, Jezova D, Alajajian B, Digicaylioglu M (August 2011). "The blood–spinal cord barrier: Morphology and Clinical Implications". Annals of Neurology. 70(2):194-206. https://doi-org.prox.lib.ncsu.edu/10.1002/ana.22421
  • Sauer R, Kirchner J, Yang D, Hu L, Leinders M, Sommer C, Brack A, Rittner HL (October 2017). "Blood–spinal cord barrier breakdown and pericyte deficiency in peripheral neuropathy". Annals of the New York Academy of Sciences. 1405(1):71-88. https://doi-org.prox.lib.ncsu.edu/10.1111/nyas.13436

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Garbuzova-Davis S, Saporta S, Haller E, Kolomey I, Bennett SP, Potter H, Sanberg PR (November 2017). "Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS." PLoS One. 2(11):e1205. doi: 10.1371/journal.pone.0001205. PMID 18030339; PMCID: PMC2075163.
  • Winkler EA, Sengillo JD, Sullivan JS, Henkel JS, Appel SH, Zlokovic BV (January 2013). "Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis". Acta Neuropathology. 125(1):111-120. doi: 10.1007/s00401-012-1039-8. Epub 2012 Sep 1. PMID 22941226; PMCID: PMC3535352.
  • Zhong Z, Deane R, Ali Z, Parisi M, Shapovalov Y, O'Banion MK, Stojanovic K, Sagare A, Boillee S, Cleveland DW, Zlokovic BV (April 2008). "ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration". Nature Neuroscience. (4):420-2. doi: 10.1038/nn2073. Epub 2008 Mar 16. PMID 18344992; PMCID: PMC2895310.
  • Huang WJ, Chen WW, Zhang X (June 2017). "Multiple sclerosis: Pathology, diagnosis and treatments." Experiments in Therapeutic Medicine. 13(6):3163-3166. doi: 10.3892/etm.2017.4410. Epub 2017 Apr 28. PMID 28588671; PMCID: PMC5450788.
  • Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, Freeman R, Truini A, Attal N, Finnerup NB, Eccleston C, Kalso E, Bennett DL, Dworkin RH, Raja SN (February 2017). "Neuropathic pain." Nature Reviews Disease Primers. 3:17002. doi: 10.1038/nrdp.2017.2. PMID 28205574; PMCID: PMC5371025.
  • Murnion BP (June 2018). "Neuropathic pain: current definition and review of drug treatment." Australian Prescriber. 41(3):60-63. doi: 10.18773/austprescr.2018.022. Epub 2018 Jun 1. PMID 29921999; PMCID: PMC6003018.
  • Li HL, Huang Y, Zhou YL, Teng RH, Zhou SZ, Lin JP, Yang Y, Zhu SM, Xu H, Yao YX (March 2020). "C-X-C Motif Chemokine 10 Contributes to the Development of Neuropathic Pain by Increasing the Permeability of the Blood-Spinal Cord Barrier". Frontiers in Immunology. 11:477. doi: 10.3389/fimmu.2020.00477. PMID 32265928; PMCID: PMC7098954.
  • Chan GN, Evans RA, Banks DB, Mesev EV, Miller DS, Cannon RE. Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model. Neurosci Lett. 2017 Feb 3;639:103-113. doi: 10.1016/j.neulet.2016.12.049. Epub 2016 Dec 21. PMID 28011392; PMCID: PMC5278641.
  • Upadhyay RK. Drug delivery systems, CNS protection, and the blood brain barrier. Biomed Res Int. 2014;2014:869269. doi: 10.1155/2014/869269. Epub 2014 Jul 20. PMID 25136634; PMCID: PMC4127280.
  • Chenthamara D, Subramaniam S, Ramakrishnan SG, Krishnaswamy S, Essa MM, Lin FH, Qoronfleh MW. Therapeutic efficacy of nanoparticles and routes of administration. Biomater Res. 2019 Nov 21;23:20. doi: 10.1186/s40824-019-0166-x. PMID 31832232; PMCID: PMC6869321.